Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Hubei Beike And Stada Arzneimittel Collaborate On Children's Drug In China

This article was originally published in PharmAsia News

Executive Summary

German-based Stada Arzneimittel, Europe's largest generic drug producer, and Hubei Beike Medicine Company have reached a strategic agreement to collaborate in all aspects of children's drugs in China including research and development, production and marketing. Under the agreement, Beike will be fully responsible for promoting and selling Stada's antipyretic drugs and paracetamol drops for children locally. With its professional focus on children's drug development, Beike's distribution network enjoys strong local market penetration, which extends to prefecture-level cities. (Click here for more - Chinese Language)



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts